WO2002076411A3 - Agent dermatologique pour le traitement des lesions cutanees, particulierement des brulures - Google Patents

Agent dermatologique pour le traitement des lesions cutanees, particulierement des brulures Download PDF

Info

Publication number
WO2002076411A3
WO2002076411A3 PCT/PL2002/000025 PL0200025W WO02076411A3 WO 2002076411 A3 WO2002076411 A3 WO 2002076411A3 PL 0200025 W PL0200025 W PL 0200025W WO 02076411 A3 WO02076411 A3 WO 02076411A3
Authority
WO
WIPO (PCT)
Prior art keywords
weight
parts
treatment
skin trauma
burn conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/PL2002/000025
Other languages
English (en)
Other versions
WO2002076411A2 (fr
Inventor
Dorian Owoc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL34674101A external-priority patent/PL346741A1/xx
Priority claimed from PL35153602A external-priority patent/PL351536A3/xx
Application filed by Individual filed Critical Individual
Priority to AU2002241416A priority Critical patent/AU2002241416A1/en
Publication of WO2002076411A2 publication Critical patent/WO2002076411A2/fr
Publication of WO2002076411A3 publication Critical patent/WO2002076411A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Animal Husbandry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention se rapporte à un agent dermatologique pour le traitement des lésions cutanées, particulièrement des brûlures, qui contient des ingrédients actifs naturels connus formant un mélange avec un milieu de base inerte. Ledit agent contient en particulier 0,1-20,0 parts en poids d'un extrait normalisé de propolis ayant une teneur en flavonoïdes, tels que la quercétine, supérieure ou égale à 1 %, 1,0-20,0 parts en poids d'un extrait normalisé d'une matière végétale brut ayant une teneur en flavonoïdes, tels que la quercétine, supérieure ou égale à 1 % et au moins 0,1-5,0 parts en poids d'au moins un des antibiotiques dermatologiques connus, uniformément dispersé dans la base inerte du type excipient dont la quantité totale assure le complément à 100 parts en poids.
PCT/PL2002/000025 2001-03-27 2002-03-20 Agent dermatologique pour le traitement des lesions cutanees, particulierement des brulures Ceased WO2002076411A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002241416A AU2002241416A1 (en) 2001-03-27 2002-03-20 Dermatological agent for the treatment of skin trauma, especially in burn conditions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PL34674101A PL346741A1 (en) 2001-03-27 2001-03-27 Dermatological agent for treating skin injuries in particular those resulting from burns
PLP.346741 2001-03-27
PL35153602A PL351536A3 (en) 2002-01-04 2002-01-04 Dermatological agent for treating skin damages, in particular those associated with burnings
PLP.351536 2002-01-04

Publications (2)

Publication Number Publication Date
WO2002076411A2 WO2002076411A2 (fr) 2002-10-03
WO2002076411A3 true WO2002076411A3 (fr) 2003-03-20

Family

ID=26653394

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/PL2002/000025 Ceased WO2002076411A2 (fr) 2001-03-27 2002-03-20 Agent dermatologique pour le traitement des lesions cutanees, particulierement des brulures

Country Status (2)

Country Link
AU (1) AU2002241416A1 (fr)
WO (1) WO2002076411A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL355298A1 (pl) * 2002-08-01 2004-02-09 DERMAPHYT Sp.z o.o. Preparat dermatologiczny do leczenia uszkodzesigma skóry
DE20306600U1 (de) * 2003-04-29 2003-09-04 Karpfl, Peter, 47546 Kalkar Hautpflegeprodukt bzw. Wundpflegemittel
ITTO20080584A1 (it) * 2008-07-29 2010-01-30 Chiara Cesano Composizione per la rigenerazione di tessuto cutaneo e sottocutaneo senescente, relativi prodotti ed usi

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO79517A2 (fr) * 1980-07-17 1983-04-29 Intreprinderea De Antibiotice,Ro Procede d'ibtention d'un onguent antiviral procede d'obtention d'un onguent antiviral
US4748022A (en) * 1985-03-25 1988-05-31 Busciglio John A Topical composition
JPH02142734A (ja) * 1988-11-24 1990-05-31 Aoki Masayuki プロポリス併用皮膚病治療方法
EP0510318A1 (fr) * 1991-04-23 1992-10-28 Antonio Carmelo Nucera Compositions pour le traitement topique de brûlures
RU2013087C1 (ru) * 1991-05-20 1994-05-30 Научно-производственное акционерное объединение "Цветень" Крем для лечения гайморитов, острых и хронических ринитов "нази"
ES2080697A1 (es) * 1994-07-19 1996-02-01 Soria Natural S A Procedimiento para la obtencion de un cerato aplicable como crema dermatologica de uso topico.
DE19615293A1 (de) * 1996-04-18 1997-10-23 Johann Dibart Propolis-Hautproblemsalbe - Propolis-Schmerzsalbe
EP0870507A1 (fr) * 1997-04-02 1998-10-14 Farmo-Nat Ltd. Extraits synergiques d'herbes
RU2120272C1 (ru) * 1996-02-16 1998-10-20 Товарищество с ограниченной ответственностью "Биокосметическая фабрика" Зимний косметический крем для защиты кожи
RU2135155C1 (ru) * 1996-04-24 1999-08-27 Закрытое акционерное общество Научно-производственный центр "Сибирская природная косметика" Биоцидное средство для косметических изделий

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO79517A2 (fr) * 1980-07-17 1983-04-29 Intreprinderea De Antibiotice,Ro Procede d'ibtention d'un onguent antiviral procede d'obtention d'un onguent antiviral
US4748022A (en) * 1985-03-25 1988-05-31 Busciglio John A Topical composition
JPH02142734A (ja) * 1988-11-24 1990-05-31 Aoki Masayuki プロポリス併用皮膚病治療方法
EP0510318A1 (fr) * 1991-04-23 1992-10-28 Antonio Carmelo Nucera Compositions pour le traitement topique de brûlures
RU2013087C1 (ru) * 1991-05-20 1994-05-30 Научно-производственное акционерное объединение "Цветень" Крем для лечения гайморитов, острых и хронических ринитов "нази"
ES2080697A1 (es) * 1994-07-19 1996-02-01 Soria Natural S A Procedimiento para la obtencion de un cerato aplicable como crema dermatologica de uso topico.
RU2120272C1 (ru) * 1996-02-16 1998-10-20 Товарищество с ограниченной ответственностью "Биокосметическая фабрика" Зимний косметический крем для защиты кожи
DE19615293A1 (de) * 1996-04-18 1997-10-23 Johann Dibart Propolis-Hautproblemsalbe - Propolis-Schmerzsalbe
RU2135155C1 (ru) * 1996-04-24 1999-08-27 Закрытое акционерное общество Научно-производственный центр "Сибирская природная косметика" Биоцидное средство для косметических изделий
EP0870507A1 (fr) * 1997-04-02 1998-10-14 Farmo-Nat Ltd. Extraits synergiques d'herbes

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 198307, Derwent World Patents Index; Class B04, AN 1983-16689K, XP002208879 *
DATABASE WPI Section Ch Week 199506, Derwent World Patents Index; Class B04, AN 1995-042015, XP002219755 *
DATABASE WPI Section Ch Week 199612, Derwent World Patents Index; Class B04, AN 1996-107601, XP002208881 *
DATABASE WPI Section Ch Week 200012, Derwent World Patents Index; Class A25, AN 2000-135445, XP002219756 *
DATABASE WPI Section Ch Week 200035, Derwent World Patents Index; Class B04, AN 2000-409139, XP002208880 *
MANZATU OAN ET AL: "Therapeutic ointment for treatment of wounds and burns", CHEMABS, XP002179925 *
NISTOR CONSTANTIN ET AL: "Sunscreen cream", CHEMABS, XP002179926 *
PATENT ABSTRACTS OF JAPAN vol. 014, no. 386 (C - 0750) 21 August 1990 (1990-08-21) *

Also Published As

Publication number Publication date
WO2002076411A2 (fr) 2002-10-03
AU2002241416A1 (en) 2002-10-08

Similar Documents

Publication Publication Date Title
EP1642501A3 (fr) Compositions synergiques comportant lufenuron et fenoxycarb
CA2289648A1 (fr) Compositions a base d'acides linoleiques conjugues
AU2317399A (en) Cereal products with inulin and methods of preparation
HUT58511A (en) Process for producing pharmaceutical compositions comprising toremifen and its metabolites, suitable for ceasing the simultaneous resistance of cancer cells to several cytotoxic active ingredients
CA2193337A1 (fr) Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
WO2000003684A3 (fr) Formulations au soja et utilisation de ces dernieres pour ameliorer la sante
WO2002035943A3 (fr) Composition et methode
CA2215883A1 (fr) Produits de panure
NO20006182D0 (no) Sammensetninger omfattende fett-opplöselige vitaminer
EP0824152A3 (fr) Préparation microbielle de vitamine B12 et préparation et utilisation de compositions ayant une concentration élevée en vitamine B12
DK1190024T3 (da) Druekerner, koldpresset druekerneolie, druekvas og druekernemel
EP1133279B1 (fr) Technique de production de poudre vitaminee
CA2098893A1 (fr) Composition antioxydante de produits naturels et methode de production de celle-ci
WO2002076411A3 (fr) Agent dermatologique pour le traitement des lesions cutanees, particulierement des brulures
WO2006032115A3 (fr) Composition contre des maladies cardio-vasculaires
WO2000026399A3 (fr) Procede de production de derives de quercetine et d'isoquercetine
CA2505500A1 (fr) Methodes de stimulation de la croissance des cheveux au moyen de benzopyranes
WO2000010525A3 (fr) Composition gelatineuse de poisson utilisee comme ingredient dans des comprimes
EP1029545A3 (fr) Composition orale pour l'administration de compléments alimentaires ou de médicaments sous forme de tablettes
PL360652A1 (en) Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
AU2001278804A1 (en) 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
EP2289350A3 (fr) Compositions pour pâtes comprenant un agent antimicrobien naturel
WO2001022917A8 (fr) Compositions effervescentes comportant du nimesulide
CA2212192A1 (fr) Preparation de graines amollies pour compositions alimentaires; emballage des graines amollies pretes pour utilisation
EP0240274A3 (fr) Avermectine comme agents pour promotion de la croissance

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AU BG BR CA CN CZ DZ EE HU ID IL IN JP KP KR LR LT LV MA MK MN MX NZ PH RO SD SI SK TN UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP